Your browser doesn't support javascript.
loading
Flow cytometric analysis of myelodysplasia: Pre-analytical and technical issues-Recommendations from the European LeukemiaNet.
van der Velden, Vincent H J; Preijers, Frank; Johansson, Ulrika; Westers, Theresia M; Dunlop, Alan; Porwit, Anna; Béné, Marie C; Valent, Peter; Te Marvelde, Jeroen; Wagner-Ballon, Orianne; Oelschlaegel, Uta; Saft, Leonie; Kordasti, Sharham; Ireland, Robin; Cremers, Eline; Alhan, Canan; Duetz, Carolien; Hobo, Willemijn; Chapuis, Nicolas; Fontenay, Michaela; Bettelheim, Peter; Eidenshink-Brodersen, Lisa; Font, Patricia; Loken, Michael R; Matarraz, Sergio; Ogata, Kiyoyuki; Orfao, Alberto; Psarra, Katherina; Subirá, Dolores; Wells, Denise A; Della Porta, Matteo G; Burbury, Kate; Bellos, Frauke; Weiß, Elisabeth; Kern, Wolfgang; van de Loosdrecht, Arjan.
Afiliação
  • van der Velden VHJ; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Preijers F; Department of Laboratory Medicine - Laboratory for Hematology, Radboudumc, Nijmegen, The Netherlands.
  • Johansson U; Laboratory Medicine, SI-HMDS, University Hospitals Bristol and Weston NHS Foundation Trust, Bristol, UK.
  • Westers TM; Department of Hematology, Amsterdam UMC, location VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Dunlop A; Department of Haemato-Oncology, Royal Marsden Hospital, Sutton, Surrey, UK.
  • Porwit A; Department of Clinical Sciences, Division of Oncology And Pathology, Faculty of Medicine, Lund University, Lund, Sweden.
  • Béné MC; Hematology Biology, Nantes University Hospital and CRCINA, Nantes, France.
  • Valent P; Department of Internal Medicine I, Division of Hematology & Hemostaseology, Medical University of Vienna, Vienna, Austria.
  • Te Marvelde J; Ludwig Boltzmann Institute for Hematology and Oncology, Medical University of Vienna, Vienna, Austria.
  • Wagner-Ballon O; Laboratory Medical Immunology, Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands.
  • Oelschlaegel U; Department of Hematology and Immunology; and Université Paris-Est Créteil, Assistance Publique-Hôpitaux de Paris, University Hospital Henri Mondor, Inserm U955, Créteil, France.
  • Saft L; Department of Internal Medicine, University Hospital Carl-Gustav-Carus, Dresden, TU, Germany.
  • Kordasti S; Department of Clinical Pathology and Oncology, Karolinska University Hospital and Institute, Solna, Stockholm, Sweden.
  • Ireland R; Comprehensive Cancer Centre, King's College London and Hematology Department, Guy's Hospital, London, UK.
  • Cremers E; Comprehensive Cancer Centre, King's College London and Hematology Department, Guy's Hospital, London, UK.
  • Alhan C; Department of Internal Medicine, Division of Hematology, Maastricht University Medical Center, AZ, Maastricht, The Netherlands.
  • Duetz C; Department of Hematology, Amsterdam UMC, location VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Hobo W; Department of Hematology, Amsterdam UMC, location VU University Medical Center, Cancer Center Amsterdam, Amsterdam, The Netherlands.
  • Chapuis N; Department of Laboratory Medicine - Laboratory for Hematology, Radboudumc, Nijmegen, The Netherlands.
  • Fontenay M; Assistance Publique-Hôpitaux de Paris. Centre-Université de Paris, Cochin Hospital, Laboratory of Hematology and Université de Paris, Institut Cochin, INSERM U1016, CNRS UMR8104, Paris, France.
  • Bettelheim P; Assistance Publique-Hôpitaux de Paris. Centre-Université de Paris, Cochin Hospital, Laboratory of Hematology and Université de Paris, Institut Cochin, INSERM U1016, CNRS UMR8104, Paris, France.
  • Eidenshink-Brodersen L; Department of Internal Medicine, Ordensklinikum Linz Barmherzige Schwestern - Elisabethinen, Linz, Austria.
  • Font P; Hematologics Inc, Seattle, WA, USA.
  • Loken MR; Department of Hematology, Hospital General Universitario Gregorio Marañon-IiSGM, Madrid, Spain.
  • Matarraz S; Hematologics Inc, Seattle, WA, USA.
  • Ogata K; Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytometry Service, University of Salamanca, Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • Orfao A; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto Carlos III, Salamanca, Spain.
  • Psarra K; Metropolitan Research and Treatment Centre for Blood Disorders (MRTC Japan), Tokyo, Japan.
  • Subirá D; Cancer Research Center (IBMCC, USAL-CSIC), Department of Medicine and Cytometry Service, University of Salamanca, Institute for Biomedical Research of Salamanca (IBSAL), Salamanca, Spain.
  • Wells DA; Biomedical Research Networking Centre Consortium of Oncology (CIBERONC), Instituto Carlos III, Salamanca, Spain.
  • Della Porta MG; Immunology Histocompatibility Department, Evangelismos Hospital, Athens, Greece.
  • Burbury K; Flow Cytometry Unit. Department of Hematology, Hospital Universitario de Guadalajara, Guadalajara, Spain.
  • Bellos F; Hematologics Inc, Seattle, WA, USA.
  • Weiß E; IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy & Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.
  • Kern W; Department of Haematology, Peter MacCallum Cancer Centre, University of Melbourne, Melbourne, Australia.
  • van de Loosdrecht A; MLL Munich Leukemia Laboratory, Munich, Germany.
Cytometry B Clin Cytom ; 104(1): 15-26, 2023 01.
Article em En | MEDLINE | ID: mdl-34894176
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas Tipo de estudo: Guideline Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article